Telix Pharmaceuticals Limited Cost Of Inventories Recognised As Expense During Period
Telix Pharmaceuticals Limited (TLPPF) reported Cost Of Inventories Recognised As Expense During Period of $142.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Expense Statement › Cost of Sales
ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod · last filed 2026-02-20
AUD
| Period end | Cost Of Inventories Recognised As Expense During Period 12 month |
|---|---|
| 2024-12-31 | 35.69M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 22.62M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 9.10M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Cost Of Inventories Recognised As Expense During Period 12 month |
|---|---|
| 2025-12-31 | $142.00M 20-F · filed 2026-02-20 |
| 2024-12-31 | $23.88M 20-F · filed 2026-02-20 |
| 2023-12-31 | $13.94M 20-F · filed 2026-02-20 |